S&P Biotech ETF (LABU) Analysis –19Jan2022

S&P Biotech ETF (LABU) is best buy at current level of $21 (multi year lows), for upside targets of $50, 65, 80 and 100. Underlying Biotech Index (#XBI) has 20% annual return over 20 yrs, and LABU is 3x ETF on the underlying S&P Biotech Index, so a huge recovery and catch up rally is ahead. Investors should not miss this opportunity to buy LABU at current low rates. $50 and $65 is a reliable upside targets, and that will give 150-200% gain!!